{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T01:26:13Z","timestamp":1789694773550,"version":"4.0.1"},"reference-count":0,"publisher":"Canadian Society of Healthcare-Systems Pharmacy","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can J Hosp Pharm"],"abstract":"<jats:p>Background: Pharmaceuticals affect planetary health through environmental contamination from human excretions, improper drug disposal, and greenhouse gas emissions, derived from manufacturing as well as from use. Research suggests that patients will choose environmentally friendly options for minor ailments, but not severe conditions. To date, no Canadian research has explored patients\u2019 views on this topic.\nObjectives: To characterize the views of British Columbians regarding medication-related environmental sustainability and to determine how these views relate to medication decisions.\nMethods: A web-based survey was distributed across British Columbia from October 30, 2023, to February 29, 2024. Residents of British Columbia at least 18 years of age who could complete an online survey in English were eligible to participate. Descriptive statistics and thematic analysis were used.\nResults: A total of 255 responses were received. When presented with a scenario related to stroke, more than half of respondents (51%) preferred the medication with higher efficacy and greater environmental harm; in contrast, for scenarios involving the common cold and asthma, more than half chose the medication with lower efficacy and lower environmental harm (54% and 59%, respectively). When cost was introduced, only 54% stated they would choose the more environmentally friendly medication if it was more expensive, whereas 97% would do so if it was less expensive. Themes from open-ended questions focused on cost, manufacturer considerations, and education.\nConclusions: Respondents were willing to choose the environmentally friendly medication for less serious conditions, but not for conditions perceived as life-threatening and\/or debilitating. Cost may be a barrier to accessing environmentally friendly options. Public education opportunities may help to inform more sustainable choices. Additionally, there may be value in manufacturer regulations or policies to ensure that the environmental impact of medications is considered.\nKeywords: sustainability of medications, environment, patient perception, medication choice, medication preference\nR\u00c9SUM\u00c9\nContexte : Les produits pharmaceutiques influencent la sant\u00e9 de la plan\u00e8te par la contamination de l\u2019environnement due aux excr\u00e9tions humaines, par l\u2019\u00e9limination inad\u00e9quate des m\u00e9dicaments et par les \u00e9missions de gaz \u00e0 effet de serre, provenant \u00e0 la fois de la fabrication et de l\u2019utilisation des produits. Des recherches indiquent que les patients choisiront des options \u00e9cologiques pour des affections mineures, mais pas pour des probl\u00e8mes graves. \u00c0 ce jour, aucune recherche canadienne n\u2019a explor\u00e9 l\u2019opinion des patients \u00e0 ce sujet.\nObjectifs : Caract\u00e9riser les opinions des habitants de la Colombie- Britannique concernant la durabilit\u00e9 environnementale li\u00e9e aux m\u00e9dicaments et la mani\u00e8re dont leurs opinions influencent leurs d\u00e9cisions concernant les m\u00e9dicaments.\nM\u00e9thodologie : Un sondage en ligne a \u00e9t\u00e9 distribu\u00e9 en Colombie- Britannique du 30 octobre 2023 au 29 f\u00e9vrier 2024. Les r\u00e9sidents de la Colombie-Britannique \u00e2g\u00e9s d\u2019au moins 18 ans pouvant remplir un sondage en ligne en anglais \u00e9taient admissibles \u00e0 y participer. Des statistiques descriptives et une analyse th\u00e9matique ont \u00e9t\u00e9 utilis\u00e9es.\nR\u00e9sultats : Au total, 255 r\u00e9ponses ont \u00e9t\u00e9 re\u00e7ues. Lorsqu\u2019un sc\u00e9nario li\u00e9 \u00e0 un accident vasculaire c\u00e9r\u00e9bral (AVC) leur a \u00e9t\u00e9 pr\u00e9sent\u00e9, plus de la moiti\u00e9 des participants (51 %) pr\u00e9f\u00e9raient le m\u00e9dicament plus efficace, mais ayant aussi un plus grand impact environnemental; en revanche, pour les sc\u00e9narios impliquant le rhume et l\u2019asthme, plus de la moiti\u00e9 ont choisi le m\u00e9dicament ayant une moindre efficacit\u00e9 et un impact environnemental moins important (54 % et 59 %, respectivement). Lorsque le co\u00fbt a \u00e9t\u00e9 ajout\u00e9 aux sc\u00e9narios, seulement 54 % ont d\u00e9clar\u00e9 qu\u2019ils choisiraient le m\u00e9dicament plus respectueux de l\u2019environnement s\u2019il \u00e9tait plus cher, tandis que 97 % le feraient s\u2019il \u00e9tait moins cher. Les th\u00e8mes des r\u00e9ponses aux questions ouvertes portaient sur le co\u00fbt, les consid\u00e9rations relatives aux fabricants et l\u2019\u00e9ducation.\nConclusions : Les participants \u00e9taient pr\u00eats \u00e0 choisir des m\u00e9dicaments respectueux de l\u2019environnement pour des affections moins graves, mais pas pour des probl\u00e8mes per\u00e7us comme mena\u00e7ant la vie ou d\u00e9bilitants. Le co\u00fbt pourrait constituer un obstacle au choix des options \u00e9cologiques. L\u2019information du public pourraient aider \u00e0 l\u2019\u00e9clairer sur des choix plus durables. De plus, il pourrait \u00eatre utile d\u2019instaurer des r\u00e9glementations ou des politiques pour les fabricants afin de s\u2019assurer que l\u2019impact environnemental des m\u00e9dicaments soit pris en compte.\nMots-cl\u00e9s : durabilit\u00e9 des m\u00e9dicaments, environnement, perception des patients, choix des m\u00e9dicaments, pr\u00e9f\u00e9rence m\u00e9dicamenteuse<\/jats:p>","DOI":"10.4212\/cjhp.3707","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T16:09:12Z","timestamp":1747238952000},"source":"Crossref","is-referenced-by-count":2,"title":["Exploring the Views of British Columbians Regarding the Environmental Impact of Medication Use"],"prefix":"10.4212","volume":"78","author":[{"given":"Madison","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen Mundeep","family":"Dahri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gigi","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Legal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2732","published-online":{"date-parts":[[2025,5,14]]},"container-title":["Canadian Journal of Hospital Pharmacy"],"original-title":[],"link":[{"URL":"https:\/\/www.cjhp-online.ca\/index.php\/cjhp\/article\/download\/3707\/5622","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.cjhp-online.ca\/index.php\/cjhp\/article\/download\/3707\/5623","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.cjhp-online.ca\/index.php\/cjhp\/article\/download\/3707\/5622","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T14:40:59Z","timestamp":1751985659000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cjhp-online.ca\/index.php\/cjhp\/article\/view\/3707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":0,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,4,9]]}},"URL":"https:\/\/doi.org\/10.4212\/cjhp.3707","relation":{},"ISSN":["1920-2903","0008-4123"],"issn-type":[{"value":"1920-2903","type":"electronic"},{"value":"0008-4123","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,14]]},"article-number":"e3707"}}